◆ 会议时间：2025年5月7-10日
◆ 会议地点：美国 新奥尔良
◆ 会议简介：
2025年国际细胞与基因治疗学会(ISCT)年会将于2025年5月7-10日在美国新奥尔良举行，会议将以最先进的全体会议为特色，其中包括免疫治疗、组织工程、多能干细胞、间充质干细胞和聚焦于新技术的会议，预计有来自世界各地的2000余名专业人士与会。
国际细胞与基因治疗学会(ISCT)成立于1992年，是一个由临床医生、监管机构、技术专家和行业合作伙伴组成的全球性非营利组织，目前在全球60多个国家拥有超过2400名成员。ISCT是全球领先的开发基于细胞的疗法进行转化方面宣的领导组织，ISCT的宗旨是推动科学研究转化，为患者提供创新的细胞疗法；愿景是将细胞疗法转化为安全有效的治疗方法，以改善患者的生活。——未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)。
ISCT 2025 - International Society for Cell & Gene Therapy (ISCT) Annual Meeting
Date: May 7 - 10, 2025
Location: New Orleans, USA
摘要征文投稿：
ABSTRACT SUBMISSION CLOSES
January 10, 2025
NOTIFICATION OF ACCEPTANCE
February 7, 2025
ACCEPTED ABSTRACT RSVP AND REGISTRATION DEADLINE
February 24, 2025
点此提交摘要>>>Submit Abstract>>>
ABSTRACT CATEGORIES
- Mesenchymal Stem/Stromal Cells
- Hematopoietic Stem/Progenitor Cells and Engineering
- Immunotherapy (CAR-T, T Reg, NK Cells etc.)
- Exosomes/EVs
- iPSC
- Gene Editing/Gene Therapies (AAVs, LNPs, nucleotide-based therapies)
- Tissue Engineering
- Embryonic, Organ and Other Tissue Specific Stem Cells
- Process Development and Manufacturing
- Regulatory Affairs, Quality Systems, Policy, Ethics, and Patient Access
General Guidelines
- The abstract body cannot exceed 2500 characters, exclusive of the title, author block, images, and tables.
- Note that spaces count as characters.
- Ensure that any references to licensed products are labelled with their non-proprietary names.
- Abstracts must be submitted via the online Abstract Submission System. Abstracts will NOT be accepted by email, mail, or fax.
- There are limited opportunities for oral talks. Invitations to give an oral presentation are based on the quality and scope of the submitted abstract as determined through our blinded-review process.
- The inclusion of all relevant data to your topic is strongly encouraged as Reviewers will evaluate this when scoring submitted abstracts.
- ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn no later than February 24th, 2025. If not withdrawn by this deadline, all accepted abstracts will be published in the final program and abstract supplement.
- Abstract presenters MUST be registered for the meeting.
- All accepted abstracts are subject to the ISCT Embargo Policy until April 30, 2025.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
